Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Joerg Weissmann"'
Autor:
Alberto Maran, MD, Diethelm Tschoepe, MD, Maurizio Di Mauro, MD, William A. Fisher, PhD, Kurt Loeffler, PhD, Iris Vesper, MS, Sandra Bloethner, PhD, Oliver Mast, MSc, Joerg Weissmann, MD, Ildikó Amann-Zalán, MD, Annette Moritz, PhD, Christopher G. Parkin, MS, Taylor Kohut, MSc, Iain Cranston, MD, FRCP
Publikováno v:
Journal of Clinical & Translational Endocrinology, Vol 1, Iss 4, Pp 161-166 (2014)
Aims: We investigated the impact of using an integrated, strip-free system compared to the use of single-strip systems on testing frequency and glycemic control in individuals with insulin-treated diabetes. Methods: This multinational, comparative, c
Externí odkaz:
https://doaj.org/article/55bf9502e8d44a249bc3108ffc5feb72
Autor:
Wendelin Schramm, Christopher G. Parkin, Diethelm Messinger, Iris Vesper, Bernhard Kulzer, Joerg Weissmann, Ingrid Daenschel, Lutz Heinemann, Wilfried Daenschel
Publikováno v:
Diabetes Research and Clinical Practice. 144:200-212
Globally, many patients with insulin-treated type-2 diabetes are suboptimally controlled. The PDM-ProValue study program evaluated whether integrated personalized diabetes management (iPDM) has the potential to improve clinical outcomes.101 practices
Publikováno v:
Journal of Diabetes Science and Technology. 12:831-838
Background: The increasing incidence of type 2 diabetes mellitus presents as a tsunami of health problems and health care costs. Preventing this development needs to target the underlying rise in metabolic syndrome cases through obesity and unhealthy
Autor:
Joerg Weissmann, Iris Vesper, Lutz Heinemann, Bernhard Kulzer, Helena Koenig, Wendelin Schramm, Annette Moritz
Publikováno v:
Journal of Diabetes Science and Technology
Background: Integrated personalized diabetes management (iPDM) is a digitally supported therapeutic concept to improve patient-physician interaction to overcome the aspects of clinical inertia. Integrated personalized diabetes management can support
Autor:
Wilfried Daenschel, Wendelin Schramm, Joerg Weissmann, Bernhard Kulzer, Angelika Mueller, Christopher G. Parkin, Diethelm Messinger, Ingrid Daenschel, Zdenka Djuric, Iris Vesper, Lutz Heinemann, Erhard G. Siegel
Publikováno v:
Journal of Diabetes Science and Technology. 10:772-781
Background: Collaborative use of structured self-monitoring of blood glucose (SMBG) data and data management software, utilized within a 6-step cycle enables integrated Personalized Diabetes Management (PDM). The 2 PDM-ProValue studies shall assess t
Publikováno v:
J Diabetes Sci Technol
Background: The increasing offering of patch-based medical devices is accompanied by growing numbers of reported adverse skin reactions. Procedures for testing leachables according to ISO 10993 may not be optimal for lipophilic substances that can be
Autor:
Iris Vesper, Wendelin Schramm, Joerg Weissmann, Bernhard Kulzer, Diethelm Messinger, Lutz Heinemann
Publikováno v:
Diabetes. 67
Aim: The PDM-ProValue study program showed the benefit of iPDM for people with type 2 diabetes mellitus (T2D) on insulin therapy. Here, we analyze which treatment process conditions may be key for this success. Methods: The study program was conducte
Autor:
Bernhard Kulzer, Wendelin Schramm, Diethelm Messinger, Lutz Heinemann, Wilfried Dänschel, Joerg Weissmann, Ingrid Dänschel, Iris Vesper
Publikováno v:
Diabetologie und Stoffwechsel.
Fragestellung: Viele Menschen mit insulinbehandeltem Typ-2 Diabetes (T2D) erreichen nicht ihre Behandlungsziele. Das PDM-ProValue Studienprogramm untersuchte, inwieweit ein digital unterstutztes, strukturiertes Behandlungskonzept (integriertes, perso
Autor:
Wendelin Schramm, Diethelm Messinger, Bernhard Kulzer, Wilfried Dänschel, Iris Vesper, Ingrid Dänschel, Lutz Heinemann, Joerg Weissmann
Publikováno v:
Diabetologie und Stoffwechsel.
Autor:
Diethelm Messinger, Joerg Weissmann, Bernhard Kulzer, Lutz Heinemann, Wilfried Dänschel, Iris Vesper, Ingrid Dänschel, Wendelin Schramm
Publikováno v:
Diabetologie und Stoffwechsel.
Fragestellung: Die Wirksamkeit von iPDM, einem digital unterstutzten, strukturierten Behandlungskonzept, wurde im PDM-ProValue Studienprogramm bei insulinbehandelten Patienten mit Typ-2 Diabetes (T2D) untersucht. Neben klinischen Parametern wurden di